[FATE] QoQ Quarter Result on 30-Jun-2024 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
13-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 19.95%
YoY- 27.16%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 3,074 6,772 1,925 1,676 1,944 933 58,980 -85.97%
PBT -47,678 -38,427 -48,004 -44,122 -45,170 -52,755 -18,881 85.12%
Tax 0 0 4,778 18,832 -4,740 -4,381 -9,711 -
NP -47,678 -38,427 -48,004 -44,122 -45,170 -52,755 -9,170 199.22%
Tax Rate - - - - - - - -
Total Cost 50,752 45,199 49,929 45,798 47,114 53,688 68,150 -17.79%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -1,551.01 -567.44 -2,493.71 -2,632.58 -2,323.56 -5,654.34 -15.55 2032.79%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.40 -0.33 -0.47 -0.45 -0.46 -0.54 -0.09 169.58%
EPS Diluted -0.40 -0.33 -0.47 -0.45 -0.46 -0.54 -0.09 169.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.